Zivo Bioscience Inc. Warrants (NASDAQ:ZIVOW) — Market Cap & Net Worth
Market Cap & Net Worth: Zivo Bioscience Inc. Warrants (ZIVOW)
Zivo Bioscience Inc. Warrants (NASDAQ:ZIVOW) has a market capitalization of $0.97 ($0.97) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #32051 globally and #6453 in its home market, demonstrating a -99.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zivo Bioscience Inc. Warrants's stock price $0.00 by its total outstanding shares 9706 (9.71K). Also see ZIVOW total asset value for a full breakdown of the balance sheet.
Zivo Bioscience Inc. Warrants Market Cap History: 2021 to 2026
Zivo Bioscience Inc. Warrants's market capitalization history from 2021 to 2026. Data shows change from $9.12K to $0.97 (-83.55% CAGR). Also see Zivo Bioscience Inc. Warrants operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Zivo Bioscience Inc. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zivo Bioscience Inc. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ZIVOW stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.09x
Zivo Bioscience Inc. Warrants's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $388.24 | $27.65K | -$7.78 Million | 0.01x | N/A |
| 2024 | $14.56K | $157.22K | -$13.38 Million | 0.09x | N/A |
Competitor Companies of ZIVOW by Market Capitalization
Companies near Zivo Bioscience Inc. Warrants in the global market cap rankings as of September 17, 2026. Review ZIVOW intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Zivo Bioscience Inc. Warrants by market ranking:
- Neovacs S.A. (PA:ALNEV): Ranked #32042 globally with a market cap of $13.63 USD ( €11.66 EUR).
- Lexaria Bioscience Corp (NASDAQ:LEXXW): Ranked #32043 globally with a market cap of $11.49 USD.
- BELLHAVEN COPPER (F:4BL): Ranked #32052 globally with a market cap of $0.00 USD.
- NVIDIA Corporation (NASDAQ:NVDA): Ranked #1 globally with a market cap of $5.06 Trillion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #32042 | Neovacs S.A. | PA:ALNEV | $13.63 | €0.25 |
| #32043 | Lexaria Bioscience Corp | NASDAQ:LEXXW | $11.49 | $0.00 |
| #32052 | BELLHAVEN COPPER | F:4BL | $0.00 | €2.56 |
| #1 | NVIDIA Corporation | NASDAQ:NVDA | $5.06 Trillion | $213.90 |
Zivo Bioscience Inc. Warrants Historical Marketcap From 2021 to 2026
Between 2021 and today, Zivo Bioscience Inc. Warrants's market cap moved from $9.12K to $ 0.97, with a yearly change of -83.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $0.97 | -99.92% |
| 2025 | $1.27K | -91.25% |
| 2024 | $14.56K | +3650.00% |
| 2023 | $388.24 | -94.81% |
| 2022 | $7.48K | -18.06% |
| 2021 | $9.12K | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Zivo Bioscience Inc. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $0.97 USD |
| MoneyControl | $0.97 USD |
| MarketWatch | $0.97 USD |
| marketcap.company | $0.97 USD |
| Reuters | $0.97 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zivo Bioscience Inc. Warrants
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically act… Read more